Angioedema

Deployment o the Multidisciplinary Prospective Cohort Imminent

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

Lanadelumab in Long-term Prophylaxis of Acquired Angioedema

A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada

A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor

Mepolizumab in Episodic Angioedema With Eosinophilia

Lanadelumab in Bradykinin Angioedema

Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

Angioedema Biomarker Research Study

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment

Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

CLOUD-R HAE REGISTRY

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

Determination of Specific Biomarkers of Angioneurotic Crisis